Form 4 for GYRE GYRE THERAPEUTICS, INC.
Accepted 2026-06-15 16:01:12 ET · period of report 2026-06-11 · accession 0001140361-26-025208 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-15 16:01 | 2026-06-11 | GYRE | Ye Weiguo | COO | M - OptEx | $0.75 | +2,800 | 702.8K | +0.4% | +$2,100 |
| D | 2026-06-15 16:01 | 2026-06-11 | GYRE | Ye Weiguo | COO | S - Sale+OE | $6.17 | -2,800 | 700.0K | -0.4% | -$17.3K |
| D | 2026-06-15 16:01 | 2026-06-11 | GYRE | Ye Weiguo | COO | M - OptEx | $0.00 | -2,800 | 838.7K | -0.3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-11 | M | A | 2,800 | $0.75 | 702,800 | D | — | — | |
| 2 | Common | Common Stock | 2026-06-11 | S | D | 2,800 | $6.17 | 700,000 | D | — | — | (F1) The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $6.16 to $6.18. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-06-11 | M | D | 2,800 | $0.00 | 838,701 | D | $0.75 · — to 2030-10-31 | 2,800 Common Stock | (F2) These options are vested in full. |